id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2018-N-0371-0001,FDA,FDA-2018-N-0371,Medical Devices; Neurological Devices; Classification of the Percutaneous Nerve Stimulator for Substance Use Disorders,Rule,Final Rule,2018-02-05T05:00:00Z,2018,2,2018-02-05T05:00:00Z,,2018-02-05T17:18:35Z,2018-02202,0,0,0900006482eea4d9